Rajesh Kotcherlakota

Title: Innovations of Rajesh Kotcherlakota in Cancer Therapy

Introduction

Rajesh Kotcherlakota is an accomplished inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of cancer therapy through his innovative research and development of targeted drug delivery systems.

Latest Patents

Rajesh holds a patent for a groundbreaking formulation that utilizes gold nanoparticles for cancer treatment. The patent, titled "Gold nanoparticle based formulation for use in cancer therapy," focuses on the development of a new formulation containing gold nanoparticles (AuNPs) combined with bi-functional recombinant fusion proteins TRAF(C). This formulation is designed for the targeted delivery of anticancer drugs and nucleic acids specifically to HER2+ cancers. The engineered fusion protein TRAF(C) selectively targets HER2+ receptors that are overexpressed in ovarian cancer cells, enhancing the efficacy of the treatment.

Career Highlights

Rajesh is affiliated with the Council of Scientific and Industrial Research, where he continues to advance his research in the field of nanomedicine. His work has been recognized for its potential to improve cancer treatment outcomes through innovative drug delivery mechanisms.

Collaborations

Rajesh collaborates with notable colleagues, including Chitta Ranjan Patra and Vijaya Gopal, who contribute to his research endeavors and help in the development of new therapeutic strategies.

Conclusion

Rajesh Kotcherlakota's innovative work in developing gold nanoparticle-based formulations represents a significant advancement in cancer therapy. His contributions are paving the way for more effective treatments for patients with HER2+ cancers.